We are live on ! Find out more
Renaissance Technologies

Renaissance Technologies Portfolio holdings

AUM $63.9B
1-Year Est. Return 45.56%
 

Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.

This Fund
S&P 500
This Quarter Est. Return
+8.19%
1 Year Est. Return
+45.56%
3 Year Est. Return
+129.95%
5 Year Est. Return
+153.6%
10 Year Est. Return
+738.07%
AUM
$73.1B
AUM Growth
+$2.4B
Cap. Flow
-$1.43B
Cap. Flow %
-1.96%
Top 10 Hldgs %
11.25%
Holding
4,601
New
626
Increased
1,390
Reduced
2,018
Closed
524

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$839M
2
AMZN icon
Amazon
AMZN
+$810M
3
TSLA icon
Tesla
TSLA
+$644M
4
TSM icon
TSMC
TSM
+$546M
5
JNJ icon
Johnson & Johnson
JNJ
+$389M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$891M
2
HD icon
Home Depot
HD
+$441M
3
JPM icon
JPMorgan Chase
JPM
+$335M
4
NVO
Novo Nordisk
NVO
+$317M
5
ASML icon
ASML
ASML
+$315M

Sector Composition

Rank Sector Weight
1 Healthcare 20.81%
2 Technology 15.51%
3 Consumer Discretionary 11.84%
4 Consumer Staples 10.09%
5 Financials 9.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AIU
4001
DELISTED
Meta Data Limited American Depositary Shares, each representing ten (10) Class A Ordinary Shares
AIU
$16K ﹤0.01%
+3,060
New +$16.4K
MDVL
4002
DELISTED
MedAvail Holdings, Inc. Common Stock
MDVL
$16K ﹤0.01%
1,050
+254
+32% +$7.31K
SDIG
4003
DELISTED
Stronghold Digital Mining, Inc. Class A Common Stock
SDIG
$16K ﹤0.01%
+3,310
New +$25.1K
BAOS icon
4004
Baosheng Media Group
BAOS
$1.02M
$15K ﹤0.01%
2,893
-50
-2% -$266
CHNR icon
4005
China Natural Resources
CHNR
$4.66M
$15K ﹤0.01%
973
-20
-2% -$346
HYPR icon
4006
Hyperfine
HYPR
$88.4M
$15K ﹤0.01%
+17,500
New +$15.9K
MNTS icon
4007
Momentus
MNTS
$78.4M
$15K ﹤0.01%
+2
New +$28.8K
SRZN icon
4008
Surrozen
SRZN
$223M
$15K ﹤0.01%
+1,773
New +$37.5K
TOVX icon
4009
Theriva Biologics
TOVX
$10.1M
$15K ﹤0.01%
1,300
+32
+3% +$581
GPUS
4010
Hyperscale Data Inc
GPUS
$52.9M
$15K ﹤0.01%
+1
New +$23K
HPCO
4011
DELISTED
Hempacco Co., Inc. Common Stock
HPCO
$15K ﹤0.01%
+1,791
New +$30K
ADXN
4012
Addex Therapeutics
ADXN
$14K ﹤0.01%
1,095
-382
-26% -$5.64K
MTC icon
4013
MMTec
MTC
$371M
$14K ﹤0.01%
2,263
+150
+7% +$1.35K
WNW icon
4014
Meiwu Technology Co
WNW
$3.31M
$14K ﹤0.01%
1
AXLA
4015
DELISTED
Axcella Health Inc. Common Stock
AXLA
$14K ﹤0.01%
1,768
-384
-18% -$9.95K
VIVE
4016
DELISTED
VIVEVE MED INC
VIVE
$14K ﹤0.01%
32,000
-400
-1% -$202
NAVB
4017
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
$14K ﹤0.01%
65,333
+39,500
+153% +$9.88K
IMH
4018
DELISTED
Impac Mortgage Holdings Inc.
IMH
$14K ﹤0.01%
83,271
-2,200
-3% -$572
ITP icon
4019
IT Tech Packaging
ITP
$2.86M
$13K ﹤0.01%
29,018
-600
-2% -$402
PRPO icon
4020
Precipio
PRPO
$39.1M
$13K ﹤0.01%
1,190
+40
+3% +$602
SLE icon
4021
Super League Enterprise
SLE
$4.44M
$13K ﹤0.01%
4
ZENV
4022
DELISTED
Zenvia
ZENV
$13K ﹤0.01%
11,300
-600
-5% -$952
MGAM
4023
DELISTED
Mobile Global Esports Inc. Common Stock
MGAM
$13K ﹤0.01%
+16,183
New +$16.8K
LMNL
4024
DELISTED
Liminal BioSciences Inc. Common Shares
LMNL
$13K ﹤0.01%
3,850
-989
-20% -$4.52K
AMST icon
4025
Amesite
AMST
$5.94M
$12K ﹤0.01%
5,517
+434
+9% +$1.27K

Similar funds

Renaissance Technologies's Q4 2022 Portfolio in Review

As of Q4 2022, Renaissance Technologies held 4,601 positions worth $73.1B, up 3.4% from $70.7B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Renaissance Technologies's Q4 2022 filing shows 626 new, 1,390 increased, 2,018 reduced and 524 closed positions. Its largest new stake was Johnson & Johnson: 2,254,125 shares worth $398M. The largest sale was Microsoft, an estimated $891M.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Renaissance Technologies's largest Q4 2022 buy was Johnson & Johnson: 2,254,125 shares worth $398M.
  • Renaissance Technologies added most to Apple in Q4 2022, an estimated $839M increase.
  • Renaissance Technologies's biggest Q4 2022 reduction was Novo Nordisk, cutting an estimated $317M.
  • Renaissance Technologies fully exited Microsoft in Q4 2022, selling an estimated $891M.
  • Renaissance Technologies's ten largest holdings make up 11% of its $73.1B portfolio in Q4 2022.
  • Renaissance Technologies opened 626 new positions and closed 524 in Q4 2022.
  • Renaissance Technologies's portfolio value rose 3.4% quarter-over-quarter to $73.1B.

Based on Renaissance Technologies's 13F filing for Q4 2022, filed 13 Feb 2023.